1. Chao TF, Lip GYH*,. Liu CJ,. Lin YJ ,. Chang SL,. Lo LW,. Hu YF,. Tuan TC, Liao JN, Chung FP, Chen TJ, Chen SA*. Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients with Atrial Fibrillation. J Am Coll Cardiol. 2018;71(2):122-132.
2. Chao TF, Liu CJ, Lin YJ,. Chang SL, Lo LW,. Hu YF,. Tuan TC, Liao JN, Chung FP,. Chen TJ, Lip GYH, Chen SA*. Oral Anticoagulation in Very Elderly Patients with Atrial Fibrillation - A Nationwide Cohort Study. Circulation. 2018: 138(1):37-47.
3. Chao TF,. Lip GYH *,. Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Chen TJ, S. A. Chen*. Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities. Eur Heart J. 2019;40(19):1504-1514.
4. Chao TF,. Chiang CE, Liao JN, Chen TJ, Lip GYH*, Chen SA*.Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in the Elderly Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study. Chest. 2020;157(5):1266-1277.
5. Liao JN, Chao TF, Hung CL *, Chen SA *. The decrease in peak atrial longitudinal strain in patients with atrial fibrillation as a practical parameter for stroke risk stratification. Heart Rhythm. 2021; 18(4):538-544.

限於篇幅,以上謹為代表著作